Search

everythinglearnresearchcommunity

for

Search:↓

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Specific mutations in a receptor cause facial abnormalities and hair loss.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Belatacept may be a promising treatment for alopecia areata.

Aconiti Lateralis Preparata Radix helps mouse stem cells grow and turn into bone cells faster than usual methods.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

The Naked (N) trait in mice is linked to lower glycine and tyrosine in hair proteins.

Hair changes could indicate neurological diseases and help monitor treatment.

PMC shows promise as a treatment for hair loss.

Candida antigen is an effective and promising treatment for alopecia areata.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

A20 protein is crucial for normal skin and hair development.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

The CAP1 gene helps control ammonium levels and is necessary for the proper growth of root hairs in Arabidopsis.

DNA analysis can help tailor alopecia treatment.

SIRT3 and SIRT7 decrease, while NFATC1 and PDL-1 increase in Androgenetic Alopecia.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.